CV Technologies
This article was originally published in The Tan Sheet
Executive Summary
Initiating Phase II trial of "immune stimulant" ginseng extract CVT-E002 with $500,000 grant from Canadian government. The product is marketed in the U.S. as Cold-FX by Amrion, a division of Whole Foods, under its BioDynamax and Physio-Logics dietary supplement lines ("The Tan Sheet" March 9, p. 7). CV Technologies distributes Cold-FX in Canada. The company is planning to pursue Rx status for CVT-E002 in both countries
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning